{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:40:36Z","timestamp":1792460436223,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuroscience.2026.09.043","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:09:50Z","timestamp":1791040190000},"page":"197-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic potential of proline-rich peptide-1 (PRP-1) in counteracting amyloid-\u03b2-mediated cortical and hippocampal neurodegeneration in a rat model"],"prefix":"10.1016","volume":"618","author":[{"given":"Harutyun","family":"Stepanyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4657-8249","authenticated-orcid":false,"given":"Hamzeh","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Poghosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Danielyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2263-5267","authenticated-orcid":false,"given":"Arsen","family":"Minasyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen","family":"Hunanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira","family":"Hunanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10048-025-00821-y","article-title":"Multi-target approach to Alzheimer\u2019s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid-modulating mechanisms","volume":"26","author":"Abbas","year":"2025","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1134\/S1819712414010036","article-title":"The proline-rich hypothalamic peptide is a modulator of functions of neurotrophins and neuronal activity in amyloid-induced neurodegeneration","volume":"8","author":"Aghajanov","year":"2014","journal-title":"Neurochem. J."},{"key":"10.1016\/j.neuroscience.2026.09.043_b0015","doi-asserted-by":"crossref","DOI":"10.5114\/aoms\/201186","article-title":"Enhanced neuroprotection against Alzheimer\u2019s disease by combining Inula viscosa with curcumin: an in vitro study","author":"Alizade","year":"2025","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","article-title":"The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.043_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.61186\/jcbr.7.4.15","article-title":"The effect of apelin-13 on memory of scopolamine-treated rats and accumulation of amyloid-beta plaques in the hippocampus","volume":"7","author":"Azhir","year":"2023","journal-title":"Journal of Clinical and Basic Research"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.043_b0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.32598\/bcn.2021.666.2","article-title":"Protein kinase C involvement in neuroprotective effects of thymol and carvacrol against toxicity induced by Amyloid-\u03b2 in rat hippocampal neurons","volume":"13","author":"Azizi","year":"2022","journal-title":"Basic and Clinical Neuroscience"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1039\/C2FO30111C","article-title":"Modulation of amyloid-\u03b2 1-42 structure and toxicity by proline-rich whey peptides","volume":"4","author":"Bharadwaj","year":"2012","journal-title":"Food Funct."},{"issue":"18","key":"10.1016\/j.neuroscience.2026.09.043_b0040","doi-asserted-by":"crossref","first-page":"13900","DOI":"10.3390\/ijms241813900","article-title":"Treatment of Alzheimer\u2019s disease: beyond symptomatic therapies","volume":"24","author":"Buccellato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.09.043_b0045","first-page":"237","article-title":"Targeted drug delivery: amyloid beta targeting drugs, immunotherapy, anti-tau and aggregation inhibitor, microtubule-stabilizing, and neuroinflammation modulation","author":"Chintamaneni","year":"2025","journal-title":"Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer\u2019s Disease"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.09.043_b0050","article-title":"Alzheimer's disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14336\/AD.2021.0529","article-title":"The cause of Alzheimer\u2019s disease: the theory of multipathology convergence to chronic neuronal stress","volume":"13","author":"Decourt","year":"2022","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0060","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12035-021-02612-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for Alzheimer\u2019s disease","volume":"59","author":"Dhapola","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.043_b0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2007.10.019","article-title":"Neuroprotection by hypothalamic peptide proline-rich peptide-1 in A\u03b225\u201335 model of Alzheimer's disease","volume":"4","author":"Galoyan","year":"2008","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.09.043_b0070","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1093\/brain\/awac096","article-title":"Reimagining cholinergic therapy for Alzheimer\u2019s disease","volume":"145","author":"Giacobini","year":"2022","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.043_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi\u2010Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, challenges, and Limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.043_b0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.26444\/jpccr\/114763","article-title":"Icariin as a new potential drug in Alzheimer disease treatment\u2013a review","volume":"13","author":"Jasielski","year":"2019","journal-title":"J. Pre-Clin. Clin. Res."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.09.043_b0085","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2009.09.005","article-title":"Subcellular and metabolic examination of amyloid-\u03b2 peptides in Alzheimer disease pathogenesis: evidence for A\u03b225\u201335","volume":"221","author":"Kaminsky","year":"2010","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0095","doi-asserted-by":"crossref","first-page":"28963","DOI":"10.1038\/s41598-025-13920-5","article-title":"Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer\u2019s mice model","volume":"15","author":"Kaur","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","article-title":"Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.09.043_b0105","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1007\/s12035-025-05047-5","article-title":"Voglibose attenuates amyloid beta\u2013induced memory deficits in a rodent model: a potential Alzheimer\u2019s therapy via Wnt signaling modulation","volume":"62","author":"Manandhar","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.043_b0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1134\/S181971240804020X","article-title":"Application of a histochemical method for detection of Ca2+ dependent acid phosphatase activity for studies of morpho-functional state of the cell structures in the rat brain","volume":"2","author":"Meliksetyan","year":"2008","journal-title":"Neurochem. J."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.043_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.043_b0120","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.neuroscience.2026.09.043_b0125","doi-asserted-by":"crossref","first-page":"13008","DOI":"10.3390\/ijms232113008","article-title":"Alzheimer\u2019s disease: from immune homeostasis to neuroinflammatory condition","volume":"23","author":"Princiotta Cariddi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.043_b0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.neuroscience.2026.09.043_b0135","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.09.043_b0140","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.043_b0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.043_b0150","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers\u2013a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"issue":"3\u20134","key":"10.1016\/j.neuroscience.2026.09.043_b0155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.brainresbull.2011.08.003","article-title":"Neuroprotective action of proline-rich polypeptide-1 in \u03b2-amyloid induced neurodegeneration in rats","volume":"86","author":"Yenkoyan","year":"2011","journal-title":"Brain Res. Bull."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226006615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226006615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:15:38Z","timestamp":1792458938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226006615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S0306452226006615"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.09.043","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of proline-rich peptide-1 (PRP-1) in counteracting amyloid-\u03b2-mediated cortical and hippocampal neurodegeneration in a rat model","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}